Fluorescence‐guided surgery has emerged as a promising imaging technique for real‐time intraoperative tumour delineation and visualisation of submillimetre tumour masses in cytoreductive surgery for epithelial ovarian cancer (EOC). Researchers have developed several EOC‐targeted fluorescent probes, most of which are currently in the preclinical stage. Interestingly, imaging devices designed for open surgery are proof of concept. This review summarises the recent advances in EOC‐targeted fluorescent probes and open‐field fluorescence imaging strategies and discusses the challenges and potential solutions for clinical translation.